Log in to save to my catalogue

Spironolactone Metabolites in TOPCAT — New Insights into Regional Variation

Spironolactone Metabolites in TOPCAT — New Insights into Regional Variation

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5590224

Spironolactone Metabolites in TOPCAT — New Insights into Regional Variation

About this item

Full title

Spironolactone Metabolites in TOPCAT — New Insights into Regional Variation

Publisher

United States: Massachusetts Medical Society

Journal title

The New England journal of medicine, 2017-04, Vol.376 (17), p.1690-1692

Language

English

Formats

Publication information

Publisher

United States: Massachusetts Medical Society

More information

Scope and Contents

Contents

In a subgroup of TOPCAT participants assigned to spironolactone, the spironolactone metabolite canrenone was measured to assess adherence. Canrenone levels were undetectable in 30% of participants from Russia, as compared with only 3% from the United States and Canada.
To the Editor:
In the Treatment of Preserved Cardiac Function Heart Failur...

Alternative Titles

Full title

Spironolactone Metabolites in TOPCAT — New Insights into Regional Variation

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5590224

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5590224

Other Identifiers

ISSN

0028-4793

E-ISSN

1533-4406

DOI

10.1056/NEJMc1612601

How to access this item